AtaiBeckley (ATAI) Asset Utilization Ratio (2021 - 2026)
AtaiBeckley (ATAI) posted Asset Utilization Ratio of 0.02 for Q1 2025, up 1382.4% sequentially from 0.0 in Q2 2024, and up 2247.06% YoY from 0.0 in Q1 2024.
AtaiBeckley (ATAI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
AtaiBeckley has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.02 in Q1 2025.
- Quarterly Asset Utilization Ratio rose 2247.06% year-over-year to 0.02 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.02 (up 2247.06% YoY) and the FY2024 annual result came in at 0.0, up 29.72% from the prior year.
- Asset Utilization Ratio advanced to 0.02 in Q1 2025 per ATAI's latest filing, from 0.0 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 22.76 in Q3 2021 and troughed at 0.0 in Q4 2022.
- A 5-year average of 4.62 and a median of 0.0 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio plunged 99.99% in 2022, then jumped 2247.06% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 7.22 in 2021, then slumped by 99.99% to 0.0 in 2022, then jumped by 45.77% to 0.0 in 2023, then jumped by 49.38% to 0.0 in 2024, then jumped by 1382.4% to 0.02 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.02, 0.0, and 0.0 for Q1 2025, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.01 |
| Mar 31, 2025 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Dec 31, 2021 | 7.22 |
| Sep 30, 2021 | 22.76 |
| Jun 30, 2021 | 22.46 |
| Mar 31, 2021 | 3.01 |